KalVista Pharmaceuticals, Inc (KALV) Stock Price

13.62 ▲ +0.53 (+4.05%)
Open: 13.13 Vol: 1.45M Day's range: 12.95 - 13.87 Nov 14, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
KALV Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 13.61▲ 13.50▲ 13.48▲ 12.48▲ 11.51▲
MA10 13.58▲ 13.46▲ 13.38▲ 11.66▲ 12.05▲
MA20 13.53▲ 13.34▲ 13.13▲ 11.40▲ 12.91▲
MA50 13.44▲ 12.66▲ 11.85▲ 12.17▲ 11.67▲
MA100 13.37▲ 11.76▲ 11.41▲ 12.96▲ 11.96▲
MA200 13.15▲ 11.38▲ 11.36▲ 12.36▲ 10.98▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.008▲ -0.028▼ -0.023▼ 0.364▲ -0.194▼
RSI 63.646▲ 66.633▲ 69.574▲ 70.762▲ 55.661▲
STOCH 73.515     56.928     69.524     74.401     19.654▼
WILL %R -34.211     -15.493▲ -13.174▲ -7.225▲ -53.275    
CCI 141.707▲ 146.259▲ 117.436▲ 189.411▲ 7.664    
Latest Filters Detected On KALV
▲ RSI&STOCH $KALV Overbought RSI + Stochastic Set Alert
▲ RSI $KALV RSI(14) Crossed Above 70 Set Alert
▲ BREAK $KALV Price Breaks 30 Days High Set Alert
▲ BREAK $KALV Price Breaks 20 Days High Set Alert
▲ BREAK $KALV Price Breaks 10 Days High Set Alert
KalVista Pharmaceuticals, Inc News
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Q3 2025 Earnings Call Transcript
Wednesday, November 12, 2025 05:18 AM
Q3 2025 Earnings Call Transcript November 11, 2025 Operator: Good day, and thank you for standing by. Welcome to KalVista Pharmaceuticals’ 2025 Third Quarter Financial Update and Operating Results ...
KalVista Pharmaceuticals Inc (KALV) Q3 2026 Earnings Call Highlights: Strong EKTERLY Launch and ...
Tuesday, November 11, 2025 01:15 PM
KalVista Pharmaceuticals Inc (KALV) reports robust demand for EKTERLY, financial resilience, and strategic international expansion amid ongoing payer negotiations.
KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Provides Operational Update and Reports Third Quarter Financial Results
Monday, November 10, 2025 01:47 PM
US launch of EKTERLY® gaining strong momentum with $13.7 million in net product revenue for the third quarter 937 patient start forms received through October, reflecting rapid adoption as first ...
KALV historical stock data
date open high low close volume
14/11/25 13.13 13.87 12.95 13.62 1,448,052
13/11/25 13.09 13.36 12.88 13.09 1,302,019
12/11/25 11.55 13.44 11.46 13.34 2,724,272
11/11/25 11.39 11.75 10.55 11.47 3,423,724
10/11/25 10.98 11.10 10.63 10.89 856,368
07/11/25 10.85 10.885 10.41 10.78 803,069
06/11/25 10.97 11.32 10.765 10.89 802,250
05/11/25 10.79 11.035 10.64 10.99 870,304
04/11/25 10.69 11.045 10.51 10.76 739,667
03/11/25 10.82 11.16 10.51 10.80 1,123,994
Quote Details
52wk Low:7.30
52wk High:17.28
Vol:1.45M
Avg Vol(3m):23.9M
1Y Chng:+32.62%
1M Chng:+24.27%
Add to Watch List
More Information
Index US Composite
Market Cap. 661.65M